CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
21 hedge funds and large institutions have $18.3M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 22 → 21 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$500K | |
| 3 | +$476K | |
| 4 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$261K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$131K |
Top Sellers
| 1 | -$597K | |
| 2 | -$367K | |
| 3 | -$367K | |
| 4 |
LWP
Legacy Wealth Partners
Calabasas,
California
|
-$128K |
| 5 |
BAMG
Brand Asset Management Group
Chesterfield,
Missouri
|
-$29K |